Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick B Ryan

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
JMIR Medical Informatics|March 4, 2021
Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation StudyJenna M Reps, Chungsoo Kim, Ross D Williams, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort studyAlbert Prats-Uribe, Anthony G Sena, Lana Yin Hui Lai, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Rheumatology (Oxford, England)|March 16, 2021
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysisEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
BMC Medical Research Methodology|January 31, 2022
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international networkRoss D Williams, Aniek F Markus, Cynthia Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United StatesAsieh Golozar, Lana Yh Lai, Anthony G Sena, et al.
JAMA Ophthalmology|February 20, 2025
Semaglutide and Nonarteritic Anterior Ischemic Optic NeuropathyCindy X Cai, Michelle Hribar, Sally Baxter, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and SpainElena Roel, Andrea Pistillo, Martina Recalde, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
JMIR Medical Informatics|March 4, 2021
Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation StudyJenna M Reps, Chungsoo Kim, Ross D Williams, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort studyAlbert Prats-Uribe, Anthony G Sena, Lana Yin Hui Lai, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Rheumatology (Oxford, England)|March 16, 2021
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysisEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
BMC Medical Research Methodology|January 31, 2022
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international networkRoss D Williams, Aniek F Markus, Cynthia Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United StatesAsieh Golozar, Lana Yh Lai, Anthony G Sena, et al.
JAMA Ophthalmology|February 20, 2025
Semaglutide and Nonarteritic Anterior Ischemic Optic NeuropathyCindy X Cai, Michelle Hribar, Sally Baxter, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and SpainElena Roel, Andrea Pistillo, Martina Recalde, et al.
Pageof 17